Setting US drug prices based on prices paid in other countries could also improve affordability for Medicare beneficiaries according to a new study by researchers at Johns Hopkins, including our Michael DiStefano

Quick Read

In JAMA Pediatrics, our Yoram Unguru highlights growing number of drug shortages as a public health crisis limiting physicians’ abilities to cure patients. He proposes establishing critical medicines list as one solution

Read More

One of the more innovative recent initiatives in academic publishing is the Journal of Controversial Ideas. Not a single issue has appeared, but already it has created a lively debate in op-ed columns. Its most contentious feature is anonymous or pseudonymous contributions

Quick Read

It’s a well-known problem with clinical trials: Researchers start out saying they will look for a particular outcome—heart attacks, for example—but then report something else when they publish their results

Quick Read

Japanese scientists said Wednesday they had successfully used mouse stem cells to grow kidneys in rat embryos, using a technique that could one day help grow human kidneys for transplant

Quick Read

Only a small fraction of people who had non-fatal opioid overdoses in West Virginia received treatment in the aftermath, a new study led by our Brendan Saloner and colleagues suggests. The finding, they say, represents a missed opportunity to prevent future fatal overdoses in a state that leads the nation in these deaths

Quick Read

Students and junior investigators are more likely than senior scientists to secure crowdfunding for their research

Quick Read

And Journals Are Doing Little to Enforce Their Rules. The dean of Yale’s medical school, the incoming president of a prominent cancer group and the head of a Texas cancer center are among leading medical figures who have not accurately disclosed their relationships with drug companies

Quick Read